Form 4: Viatris Inc. Director Richard A. Mark Reports Stock Transactions

Director Richard A. Mark reports the vesting and conversion of restricted stock units (RSUs) and dividend equivalent units (DEUs) into Viatris Inc. common stock, as well as the acquisition of additional RSUs.

Summary

• Richard A. Mark, a director of Viatris Inc., reported transactions involving the company's common stock.
• On March 3, 2024, 17,970 restricted stock units (RSUs) vested and were converted into common stock at a price of $0.00.
• Additionally, 885 fractional shares were acquired due to the settlement of RSUs.
• Dividend equivalent units (DEUs) totaling 884.8005 also vested and were converted into common stock on the same date.
• On March 4, 2024, Mark acquired 18,204 additional RSUs, which will vest on March 4, 2025.
• Following these transactions, Mark directly owns 72,333 shares of Viatris Inc. common stock and 18,204 RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a director, reflecting standard compensation practices. The vesting of RSUs suggests the achievement of performance goals, which is mildly positive.

Positives

• The vesting of RSUs and DEUs indicates that performance milestones were likely met, which is generally a positive sign.

Future Outlook

The reporting person will receive shares of common stock in the future as the newly acquired RSUs vest on March 4, 2025.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge management's sentiment and confidence in the company.

Comparison to Industry Standards

• Comparing the vesting schedules and equity compensation plans of Viatris to those of its peers in the pharmaceutical industry, such as Teva Pharmaceutical Industries or Mylan (prior to its merger with Upjohn to form Viatris), would provide context on the competitiveness of its compensation packages.
• Reviewing similar Form 4 filings from directors and officers at comparable companies can offer insights into industry-standard practices for equity grants and vesting schedules.

Stakeholder Impact

• The vesting of RSUs and DEUs dilutes existing shareholders' equity to a small extent.
• The transactions provide insight into the compensation structure for Viatris's directors.

Key Dates